INVESTIGADORES
PEREZ Ana Rosa
artículos
Título:
Early double-negative thymocyte export in Trypanosoma cruzi infection is restricted by sphingosine receptors and associated with human Chagas disease
Autor/es:
AILIN LEPLETIER, LILIANE DE ALMEIDA, LUZIA DA SILVA SAMPAIO, BRUNO PAREDES, LEONARDO SANTOS, FLORENCIA GONZÁLEZ, JUAN BELOSCAR, OSCAR BOTTASSO, MARCELO EINICKER-LAMAS, ANA ROSA PEREZ, WILSON SAVINO, ALEXANDRE MORROT.
Revista:
PLOS NEGLECTED TROPICAL DISEASES
Editorial:
PUBLIC LIBRARY SCIENCE
Referencias:
Lugar: San Francisco; Año: 2014 vol. 8 p. 1 - 14
ISSN:
1935-2735
Resumen:
The protozoan parasite Trypanosoma cruzi is able to target the thymus and induce alterations of the thymic microenviromental and lymphoid compartments. Acute infection results in severe atrophy of the organ and early release of immature thymocytes into the periphery. To date, the pathophysiological effects of thymic changes promoted by parasite inducing premature release of thymocytes to the periphery has remained elusive. Herein, we show that sphingosine-1-phosphate (S1P), a potent mediator of T cell chemotaxis, plays a role in the exit of immature double-negative thymocytes in experimental Chagas disease. In thymuses from T. cruzi-infected mice we detected reduced transcription of the S1P kinase 1 and 2 genes related to S1P biosynthesis, together with increased transcription of the SGPL1 sphingosine-1-lyase gene, whose product inactivates S1P. These changes were associated with reduced intrathymic levels of bioactive S1P. Interestingly, double-negative thymocytes from infected animals expressed high levels of the S1P receptor during infection, and migrated to lower levels of S1P. Moreover, during T. cruzi infection, this thymocyte subset expresses high levels of IL-17 and TNF-alpha cytokines upon polyclonal stimulation. In vivo treatment with the S1P receptor antagonist FTY720 resulted in recovery the numbers of double-negative thymocytes in infected thymuses to physiological levels. Finally, we showed increased numbers of double-negative T cells in the peripheral blood in severe cardiac forms of human Chagas disease.